- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Tumor Vascular CD99 Inhibits Tumor Growth
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-02
DOI
10.3389/fimmu.2019.00651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consensus guidelines for the use and interpretation of angiogenesis assays
- (2018) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature
- (2018) Elisabeth J.M. Huijbers et al. VACCINE
- CD99 at the crossroads of physiology and pathology
- (2018) Michela Pasello et al. Journal of Cell Communication and Signaling
- CD99 is a therapeutic target on disease stem cells in myeloid malignancies
- (2017) Stephen S. Chung et al. Science Translational Medicine
- The revival of cancer vaccines — The eminent need to activate humoral immunity
- (2017) Elisabeth J. M. Huijbers et al. Human Vaccines & Immunotherapeutics
- Role of the tumor stroma in resistance to anti-angiogenic therapy
- (2016) Elisabeth J.M. Huijbers et al. DRUG RESISTANCE UPDATES
- Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration
- (2015) Richard L. Watson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer
- (2015) Julia Femel et al. Oncotarget
- CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
- (2014) C. Guerzoni et al. CLINICAL CANCER RESEARCH
- Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications
- (2014) Ana Teresa Amaral et al. PLoS One
- Targeted Imaging of Ewing Sarcoma in Preclinical Models Using a 64 Cu-Labeled Anti-CD99 Antibody
- (2013) Allison F. O'Neill et al. CLINICAL CANCER RESEARCH
- Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients
- (2012) A. W. Griffioen et al. CLINICAL CANCER RESEARCH
- MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor
- (2012) G-A Franzetti et al. ONCOGENE
- CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis
- (2010) M. G. Bixel et al. BLOOD
- Vaccination against the extra domain-B of fibronectin as a novel tumor therapy
- (2010) Elisabeth J. M. Huijbers et al. FASEB JOURNAL
- CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis
- (2010) Anna Rocchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Ewing's sarcoma
- (2010) Naomi J Balamuth et al. LANCET ONCOLOGY
- Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice
- (2008) E. J.A. van Wanrooij et al. CARDIOVASCULAR RESEARCH
- The Human Protein Atlas-a tool for pathology
- (2008) F Pontén et al. JOURNAL OF PATHOLOGY
- Inducible Expression of Chimeric EWS/ETS Proteins Confers Ewing's Family Tumor-Like Phenotypes to Human Mesenchymal Progenitor Cells
- (2008) Y. Miyagawa et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started